Chronic Inflammatory Demyelinating Polyneuropathy - 26 Studies Found
| Completed |
: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. : Chronic Inflammatory Demyelinating Polyneuropathy : 2013-04-01 : Drug: NPB-01 Other Name: Intravenous immunoglobulin |
| Completed |
: Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy : Chronic Inflammatory Demyelinating Polyneuropathy : 2011-06-16 |
| Completed |
: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy : Chronic Inflammatory Demyelinating Polyneuropathy : 2010-08-18 : Biological: 10% liquid formulation of human immunoglobulin Other Name: IgPro10; Privigen |
| Withdrawn |
: High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy : Chronic Inflammatory Demyelinating Polyneuropathy : 2010-11-05 : Drug: Cyclophosphamide |
| Active, not recruiting |
: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy : Chronic Inflammatory Demyelinating Polyneuropathy : 2006-01-16 : Biological: hematopoietic stem cell transplantation Autologous hematopoietic stem cell transplantation |
| Completed |
: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy :
: Drug: lipoic acid Subjects will be started on a single daily dose of 600 mg of alpha lipoic acid or plac |
| Completed |
: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) :
|
| Active, not recruiting |
: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) :
|
| Recruiting |
: Subcutaneous Immunoglobulin for CIDP : Chronic Inflammatory Demyelinating Polyneuropathy : 2014-12-12 : Drug: Immune Globulin Subcutaneous (Human) Patients who have CIDP and are on IVIG will be allowed in the |
| Recruiting |
: IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements : Chronic Inflammatory Demyelinating Polyneuropathy : 2015-03-13 : Drug: Intravenous Immunoglobulin The decision to treat with IVIg will be entirely at the discretion of t |